Prostate Cancer
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer.
May 29, 2023
Insurer coverage of prostate cancer biomarkers.
May 26, 2023
Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.
May 25, 2023
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer.
May 25, 2023
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment.
May 25, 2023